The Structure and Organization of the Human NPAT Gene

• Published in: Genomics (San Diego, Calif.) Calif.), 1997-06, Vol.42 (3), p.388-392
• Main Authors: Imai, Takashi, Sugawara, Takehiko, Nishiyama, Akiyo, Shimada, Ryoko, Ohki, Reiko, Seki, Naohiko, Sagara, Masashi, Ito, Hiroko, Yamauchi, Masatake, Hori, Tada-aki
• Format: Article
• Language: English
• Subjects: Animals; Ataxia Telangiectasia - genetics; Ataxia Telangiectasia Mutated Proteins; Base Sequence; Biological and medical sciences; Cell Cycle Proteins; Chromosome fragility (bloom syndrome, ataxia telangiectasia, fanconi anemia, x-linked mental retardation...); Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; Cosmids; DNA, Complementary; DNA-Binding Proteins; Exons; Humans; Introns; Medical genetics; Medical sciences; Mice; Molecular Sequence Data; Nuclear Proteins; Protein-Serine-Threonine Kinases; Proteins - genetics; Tumor Suppressor Proteins
• ISSN: 0888-7543; 1089-8646
• DOI: 10.1006/geno.1997.4769

Ataxia telangiectasia (AT) is an autosomal recessive gene disorder, andATM,a housekeeping gene, has been identified as the gene responsible for AT. Recently we found that another housekeeping gene,NPAT,is located upstream ofATMon human chromosome 11. The two housekeeping genes are transcribed in opposite directions and share a 0.5-kb 5′ flanking sequence. The structure and organization ofNPATwere determined by direct sequencing of cosmid clones carrying the gene and by application of the long and accurate (LA)-PCR method to amplify regions encompassing the exon/intron boundaries and all of the exons. The gene spans at least 44 kb and consists of 18 exons and 17 introns. It has been suggested that AT heterozygotes have an increased risk of developing cancer, especially breast cancer in women. Frequently, loss of heterozygosity at loci on 11q22–q24 has been observed in DNA isolated from tumors of the breast, uterine cervix, and colon, perhaps suggesting the location of a tumor suppressor gene in 11q22–q24. For investigation of the role ofNPATin AT and these tumors with allelic loss of 11q22–q24, appropriate primer sequences and PCR conditions for amplification of all theNPATexons from genomic DNA were determined. We previously reported that no recombinations are found amongAtm, Npat,andAcat1(acetoacetyl-CoA thiolase) loci as determined by fine genetic linkage mapping of the mouse AT region. The results of the LA-PCR analysis usingNPAT- andACAT-specific primers and human genomic DNA allowed us to mapACAT12 kb centromeric toNPAT.